After-hours movers: First Republic resumes free-fall despite lifeline, FedEx surges on raised guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
FedEx (FDX) PT Raised to $242 at Stifel
March 17, 2023 1:23 PM EDTStifel analyst J. Bruce Chan raised the price target on FedEx (NYSE: FDX) to $242.00 (from $222.00) while maintaining a Buy rating.
The analyst commented, "As we previewed earlier this week, a soft operating environment in F3Q23 led to top line pressure at... More
Sarepta (SRPT) sinks 20% as surprise FDA AdComm for SRP-9001 adds risk
March 17, 2023 6:52 AM EDTShares of Sarepta Therapeutics (NASDAQ: SRPT) fell 20% in pre-open trading Friday after the company announced a surprise FDA AdComm for SRP-9001, its investigational gene therapy for the treatment of Duchenne muscular dystrophy. The news comes just a few weeks after management indicated that there would be no AdComm.
While the news adds a layer of risk, most analysts still expected FDA approval at the May 29th PDUFA date.
"FDAs decision to hold a public advisory committee meeting on the SRP 9001 BLA is a change from the communicated... More
NVIDIA (NVDA) PT Raised to $305 at Citi, 'Generative AI Arms Race'
March 17, 2023 6:10 AM EDTCiti analyst Atif Malik raised the price target on NVIDIA (NASDAQ: NVDA) to $305.00 (from $245.00) while maintaining a Buy rating.
The analyst comments "We lift our TP to $305 from $245 with a bull case of $400 on accelerating generative AI adoption based on multiple cloud... More
